Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

August 2020 | 187 pages | ID: G12C2FE7167CEN
GMD Research

Abstracts

Global oral antibiotics market will reach $26.67 billion by 2030, growing by 4.0% annually over 2020-2030 driven by rising complications associated with COVID-19 epidemic, development of innovative antibiotics, and growing healthcare expenditure.

Highlighted with 89 tables and 97 figures, this 187-page report “Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global oral antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oral antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region.

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Cephalosporin

• Cefuroxime Axetil
• Cephalexin
• Cefixime
• Cefpodoxime
• Other Cephalosporin

Penicillin
Macrolides
Tetracycline
Quinolones
Sulfonamides
Aminoglycosides
Other Drug Classes

Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Cell Wall Synthesis Inhibitors
• Mycolic Acid Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Protein Synthesis Inhibitors
• Other Mechanisms

Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Natural Antibiotics
• Semi-synthetic Antibiotics
• Synthetic Antibiotics

Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Broad-spectrum Antibiotics
• Narrow-spectrum Antibiotics

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Urinary Tract Infections (UTIS)

• Upper Respiratory Tract Infections (URTI)
• Lower Respiratory Tract Infections (LRTIs)

Dental Infections

• Monotherapies
• Combined Therapies

Respiratory Tract Infections (RTIS)
Other Applications

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Brand Antibiotics
• Generic Antibiotics

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global oral antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Astellas Pharma
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Company
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
Mayne Pharma Group Ltd.
MELINTA THERAPEUTICS, INC.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY DRUG CLASS

3.1 Market Overview by Drug Class
3.2 Cephalosporin
3.3 Penicillin
3.4 Macrolides
3.5 Tetracycline
3.6 Quinolones
3.7 Sulfonamides
3.8 Aminoglycosides
3.9 Other Drug Classes

4 SEGMENTATION OF GLOBAL MARKET BY ACTION MECHANISM

4.1 Market Overview by Action Mechanism
4.2 Cell Wall Synthesis Inhibitors
4.3 Mycolic Acid Inhibitors
4.4 RNA Synthesis Inhibitors
4.5 DNA Synthesis Inhibitors
4.6 Protein Synthesis Inhibitors
4.7 Other Mechanisms

5 SEGMENTATION OF GLOBAL MARKET BY DRUG ORIGIN

5.1 Market Overview by Drug Origin
5.2 Natural Antibiotics
5.3 Semi-synthetic Antibiotics
5.4 Synthetic Antibiotics

6 SEGMENTATION OF GLOBAL MARKET BY ACTIVITY SPECTRUM

6.1 Market Overview by Activity Spectrum
6.2 Broad-spectrum Antibiotics
6.3 Narrow-spectrum Antibiotics

7 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

7.1 Market Overview by Application
7.2 Urinary Tract Infections (UTIS)
7.3 Dental Infections
  7.3.1 Monotherapies for Dental Infections
  7.3.2 Combined Therapies for Dental Infections
7.4 Respiratory Tract Infections (RTIS)
  7.4.1 Upper Respiratory Tract Infections (URTI)
  7.4.2 Lower Respiratory Tract Infections (LRTIs)
7.5 Other Applications

8 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE

8.1 Market Overview by Drug Type
8.2 Brand Antibiotics
8.3 Generic Antibiotics

9 SEGMENTATION OF GLOBAL MARKET BY REGION

9.1 Geographic Market Overview 2019-2030
9.2 North America Market 2019-2030 by Country
  9.2.1 Overview of North America Market
  9.2.2 U.S.
  9.2.3 Canada
  9.2.4 Mexico
9.3 European Market 2019-2030 by Country
  9.3.1 Overview of European Market
  9.3.2 Germany
  9.3.3 UK
  9.3.4 France
  9.3.5 Spain
  9.3.6 Italy
  9.3.7 Russia
  9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2019-2030 by Country
  9.4.1 Overview of Asia-Pacific Market
  9.4.2 Japan
  9.4.3 China
  9.4.4 Australia
  9.4.5 India
  9.4.6 South Korea
  9.4.7 Rest of APAC Region
9.5 South America Market 2019-2030 by Country
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America Market
9.6 MEA Market 2019-2030 by Country
  9.6.1 UAE
  9.6.2 Saudi Arabia
  9.6.3 South Africa
  9.6.4 Other National Markets

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Abbott Laboratories
Astellas Pharma
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Company
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
Mayne Pharma Group Ltd.
MELINTA THERAPEUTICS, INC.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.

11 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

11.1 Risk Evaluation of Global Market
11.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Oral Antibiotics Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in Global Oral Antibiotics Market
Table 3. Global Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 4. Global Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, $ mn
Table 5. Global Oral Antibiotics Market by Action Mechanism, 2019-2030, $ mn
Table 6. Global Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 7. Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, $ mn
Table 8. Global Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 9. Global Oral Antibiotics Market: Dental Infections by Type, 2019-2030, $ mn
Table 10. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, $ mn
Table 11. Global Oral Antibiotics Market by Drug Type, 2019-2030, $ bn
Table 12. Global Oral Antibiotics Market by Region, 2019-2030, $ bn
Table 13. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 14. Leading National Oral Antibiotics Market, 2019 and 2030, $ bn
Table 15. North America Oral Antibiotics Market by Country, 2019-2030, $ bn
Table 16. U.S. Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 17. U.S. Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 18. U.S. Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 19. Canada Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 20. Canada Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 21. Canada Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 22. Mexico Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 23. Mexico Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 24. Mexico Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 25. Europe Oral Antibiotics Market by Country, 2019-2030, $ bn
Table 26. Germany Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 27. Germany Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 28. Germany Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 29. UK Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 30. UK Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 31. UK Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 32. France Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 33. France Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 34. France Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 35. Spain Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 36. Spain Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 37. Spain Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 38. Italy Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 39. Italy Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 40. Italy Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 41. Russia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 42. Russia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 43. Russia Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 44. Oral Antibiotics Market in Rest of Europe by Country, 2019-2030, $ bn
Table 45. APAC Oral Antibiotics Market by Country, 2019-2030, $ bn
Table 46. Japan Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 47. Japan Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 48. Japan Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 49. China Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 50. China Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 51. China Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 52. Australia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 53. Australia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 54. Australia Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 55. India Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 56. India Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 57. India Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 58. South Korea Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 59. South Korea Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 60. South Korea Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 61. Oral Antibiotics Market in Rest of APAC by Country, 2019-2030, $ bn
Table 62. South America Oral Antibiotics Market by Country, 2019-2030, $ bn
Table 63. Argentina Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 64. Argentina Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 65. Argentina Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 66. Brazil Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 67. Brazil Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 68. Brazil Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 69. Chile Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 70. Chile Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 71. Chile Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 72. MEA Oral Antibiotics Market by Country, 2019-2030, $ bn
Table 73. UAE Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 74. UAE Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 75. UAE Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 76. Saudi Arabia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 77. Saudi Arabia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 78. Saudi Arabia Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 79. South Africa Oral Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 80. South Africa Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 81. South Africa Oral Antibiotics Market by Application, 2019-2030, $ mn
Table 82. Breakdown of Global Market by Key Vendor, 2019, %
Table 83. Abbott Laboratories: Company Snapshot
Table 84. Abbott Laboratories: Business Segmentation
Table 85. Abbott Laboratories: Product Portfolio
Table 86. Abbott Laboratories: Revenue, 2016-2018, $ mn
Table 87. Abbott Laboratories: Recent Developments
Table 88. Risk Evaluation for Investing in Global Market, 2019-2030
Table 89. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Oral Antibiotics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Oral Antibiotics Market
Figure 8. GDP per capita in the World, 1960-2018, $ thousand
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 10. Primary Restraints and Impact Factors of Global Oral Antibiotics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Oral Antibiotics Market
Figure 13. Breakdown of Global Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue
Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%)
Figure 15. Global Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn
Figure 16. Global Oral Antibiotics Market: Penicillin, 2019-2030, $ mn
Figure 17. Global Oral Antibiotics Market: Macrolides, 2019-2030, $ mn
Figure 18. Global Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn
Figure 19. Global Oral Antibiotics Market: Quinolones, 2019-2030, $ mn
Figure 20. Global Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn
Figure 21. Global Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn
Figure 22. Global Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn
Figure 23. Breakdown of Global Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue
Figure 24. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%)
Figure 25. Global Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn
Figure 26. Global Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn
Figure 27. Global Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn
Figure 28. Global Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn
Figure 29. Global Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn
Figure 30. Global Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn
Figure 31. Breakdown of Global Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue
Figure 32. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%)
Figure 33. Global Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn
Figure 34. Global Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn
Figure 35. Global Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn
Figure 36. Breakdown of Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue
Figure 37. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%)
Figure 38. Global Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn
Figure 39. Global Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn
Figure 40. Breakdown of Global Oral Antibiotics Market by Application, 2019-2030, % of Revenue
Figure 41. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 42. Global Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn
Figure 43. Global Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn
Figure 44. Global Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn
Figure 45. Global Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn
Figure 46. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn
Figure 47. Global Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn
Figure 48. Global Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn
Figure 49. Global Oral Antibiotics Market: Other Applications, 2019-2030, $ mn
Figure 50. Breakdown of Global Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue
Figure 51. Global Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%)
Figure 52. Global Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn
Figure 53. Global Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn
Figure 54. Global Market Snapshot by Region
Figure 55. Geographic Spread of Worldwide Oral Antibiotics Market, 2019-2030, % of Sales Revenue
Figure 56. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%)
Figure 57. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 58. North American Oral Antibiotics Market, 2019-2030, $ bn
Figure 59. Breakdown of North America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 60. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 61. U.S. Oral Antibiotics Market, 2019-2030, $ bn
Figure 62. Rising Incidence of Infectious Disease in U.S.
Figure 63. Canada Oral Antibiotics Market, 2019-2030, $ bn
Figure 64. Oral Antibiotics Market in Mexico, 2015-2030, $ bn
Figure 65. European Oral Antibiotics Market, 2019-2030, $ bn
Figure 66. Breakdown of European Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 67. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 68. Oral Antibiotics Market in Germany, 2019-2030, $ bn
Figure 69. Oral Antibiotics Market in UK, 2019-2030, $ bn
Figure 70. Oral Antibiotics Market in France, 2019-2030, $ bn
Figure 71. Oral Antibiotics Market in Spain, 2019-2030, $ bn
Figure 72. Oral Antibiotics Market in Italy, 2019-2030, $ bn
Figure 73. Oral Antibiotics Market in Russia, 2019-2030, $ bn
Figure 74. Oral Antibiotics Market in Rest of Europe, 2019-2030, $ bn
Figure 75. Asia-Pacific Oral Antibiotics Market, 2019-2030, $ bn
Figure 76. Breakdown of APAC Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 77. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 78. Oral Antibiotics Market in Japan, 2019-2030, $ bn
Figure 79. Oral Antibiotics Market in China, 2019-2030, $ bn
Figure 80. Oral Antibiotics Market in Australia, 2019-2030, $ bn
Figure 81. Oral Antibiotics Market in India, 2019-2030, $ bn
Figure 82. Oral Antibiotics Market in South Korea, 2019-2030, $ bn
Figure 83. Oral Antibiotics Market in Rest of APAC, 2019-2030, $ bn
Figure 84. South America Oral Antibiotics Market, 2019-2030, $ bn
Figure 85. Breakdown of South America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 86. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 87. Oral Antibiotics Market in Argentina, 2019-2030, $ bn
Figure 88. Oral Antibiotics Market in Brazil, 2019-2030, $ bn
Figure 89. Oral Antibiotics Market in Chile, 2019-2030, $ bn
Figure 90. Oral Antibiotics Market in Rest of South America, 2019-2030, $ bn
Figure 91. Oral Antibiotics Market in Middle East and Africa (MEA), 2019-2030, $ bn
Figure 92. Breakdown of MEA Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 93. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 94. Oral Antibiotics Market in UAE, 2019-2030, $ bn
Figure 95. Oral Antibiotics Market in Saudi Arabia, 2019-2030, $ bn
Figure 96. Oral Antibiotics Market in South Africa, 2019-2030, $ bn
Figure 97. Growth Stage of Global Oral Antibiotics Industry over the Forecast Period

COMPANIES MENTIONED

Abbott Laboratories
Astellas Pharma
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Company
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
Mayne Pharma Group Ltd.
MELINTA THERAPEUTICS, INC.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.